Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Florian Geismann

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Perfusion|February 22, 2021
ECMO in COVID-19-prolonged therapy needed? A retrospective analysis of outcome and prognostic factorsEsther Dreier, Maximilian Valentin Malfertheiner, Thomas Dienemann, et al.
Infection|July 15, 2026
Pathogen patterns in viral ARDS on V-V ECMO: a single-center experienceJannis Krais, Matthias Lubnow, Alois Philipp, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|January 7, 2021
Secondary hemophagocytic lymphohistiocytosis and severe liver injury induced by hepatic SARS-CoV-2 infection unmasking Wilson's disease: Balancing immunosuppressionMatthias Lubnow, Barbara Schmidt, Martin Fleck, et al.
Critical Care (London, England)|August 19, 2025
Liberal or restrictive transfusion for veno-arterial extracorporeal membrane oxygenation patients: a target trial emulation using the OBLEX study dataLe Thi Phuong Thao, Hergen Buscher, Tri-Long Nguyen, et al.
The Journal of Clinical Investigation|November 15, 2021
Metabolic imbalance of T cells in COVID-19 is hallmarked by basigin and mitigated by dexamethasonePeter J Siska, Sonja-Maria Decking, Nathalie Babl, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Perfusion|February 22, 2021
ECMO in COVID-19-prolonged therapy needed? A retrospective analysis of outcome and prognostic factorsEsther Dreier, Maximilian Valentin Malfertheiner, Thomas Dienemann, et al.
Infection|July 15, 2026
Pathogen patterns in viral ARDS on V-V ECMO: a single-center experienceJannis Krais, Matthias Lubnow, Alois Philipp, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|January 7, 2021
Secondary hemophagocytic lymphohistiocytosis and severe liver injury induced by hepatic SARS-CoV-2 infection unmasking Wilson's disease: Balancing immunosuppressionMatthias Lubnow, Barbara Schmidt, Martin Fleck, et al.
Critical Care (London, England)|August 19, 2025
Liberal or restrictive transfusion for veno-arterial extracorporeal membrane oxygenation patients: a target trial emulation using the OBLEX study dataLe Thi Phuong Thao, Hergen Buscher, Tri-Long Nguyen, et al.
The Journal of Clinical Investigation|November 15, 2021
Metabolic imbalance of T cells in COVID-19 is hallmarked by basigin and mitigated by dexamethasonePeter J Siska, Sonja-Maria Decking, Nathalie Babl, et al.
Pageof 2